Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R Peskind

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
The Journal of Clinical Psychiatry|January 1, 1996
Neurobiology of Alzheimer's diseaseE R Peskind
The Journal of Clinical Psychiatry|August 28, 1998
Pharmacologic approaches to cognitive deficits in Alzheimer's diseaseE R Peskind
The Medical Clinics of North America|May 15, 2001
Alzheimer's disease and related disordersM A Raskind, E R Peskind
Alzheimer Disease and Associated Disorders|January 1, 1994
Neurobiologic bases of noncognitive behavioral problems in Alzheimer diseaseM A Raskind, E R Peskind
Neuroendocrinology|January 1, 1997
Decreased hypothalamic-pituitary-adrenal axis sensitivity to cortisol feedback inhibition in human agingC W Wilkinson, E R Peskind, M A Raskind
Neurology|July 6, 2000
Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study GroupM A Raskind, E R Peskind, T Wessel, et al.
Biological Psychiatry|September 24, 1999
Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's diseaseM A Raskind, E R Peskind, C Holmes, et al.
Psychiatry Research|July 7, 2001
Biological markers and diagnostic accuracy in the genetics of posttraumatic stress disorderA Radant, D Tsuang, E R Peskind, et al.
Archives of General Psychiatry|April 1, 1984
Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's diseaseM A Raskind, E R Peskind, J B Halter, et al.
Psychiatric Services (Washington, D.C.)|September 6, 2000
Group therapy program for African-American veterans with posttraumatic stress disorderL Jones, D Brazel, E R Peskind, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Psychiatry|January 1, 1996
Neurobiology of Alzheimer's diseaseE R Peskind
The Journal of Clinical Psychiatry|August 28, 1998
Pharmacologic approaches to cognitive deficits in Alzheimer's diseaseE R Peskind
The Medical Clinics of North America|May 15, 2001
Alzheimer's disease and related disordersM A Raskind, E R Peskind
Alzheimer Disease and Associated Disorders|January 1, 1994
Neurobiologic bases of noncognitive behavioral problems in Alzheimer diseaseM A Raskind, E R Peskind
Neuroendocrinology|January 1, 1997
Decreased hypothalamic-pituitary-adrenal axis sensitivity to cortisol feedback inhibition in human agingC W Wilkinson, E R Peskind, M A Raskind
Neurology|July 6, 2000
Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study GroupM A Raskind, E R Peskind, T Wessel, et al.
Biological Psychiatry|September 24, 1999
Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's diseaseM A Raskind, E R Peskind, C Holmes, et al.
Psychiatry Research|July 7, 2001
Biological markers and diagnostic accuracy in the genetics of posttraumatic stress disorderA Radant, D Tsuang, E R Peskind, et al.
Archives of General Psychiatry|April 1, 1984
Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's diseaseM A Raskind, E R Peskind, J B Halter, et al.
Psychiatric Services (Washington, D.C.)|September 6, 2000
Group therapy program for African-American veterans with posttraumatic stress disorderL Jones, D Brazel, E R Peskind, et al.
Pageof 8